MetaADEDB 2.0 @ LMMD
ciprofibrate
(KPSRODZRAIWAKH-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)C(Oc1ccc(cc1)C1CC1(Cl)Cl)(C)C
Type(s)
Approved; Investigational
ATC code(s)
C10AB08
Molecular Formula:
C13H14Cl2O3
Molecular Weight:
289.154
Log P:
3.5898
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
46.53
CAS Number(s):
52214-84-3
Synonym(s)
1.
ciprofibrate
2.
Hyperlipen
3.
Lipanor
4.
Modalim
5.
Oroxadin
6.
Win 35,833
External Link(s)
MeSHC019304
PubChem Compound2763
BindingDB50371235
ChEBI50867
CHEMBLCHEMBL557555
DrugBankDB09064
DrugCentral658
IUPHAR/BPS Guide to PHARMACOLOGY3438
KEGGdr:D03521
Therapeutic Target DatabaseD0EJ6O
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Ammonia increasedOFFSIDES
2AmphetaminesOFFSIDES
3Anal abscessOFFSIDES
4AnuriaOFFSIDES
5ApathyOFFSIDES
6Blood pressure fluctuationOFFSIDES
7Blood pressure inadequately controlledOFFSIDES
8Blood prolactin decreasedOFFSIDES
9Blood sodiumOFFSIDES
10Blood triglycerides increasedOFFSIDES
11Body TemperatureOFFSIDES
12BradycardiaOFFSIDES
13Cardiovascular Diseases10402106CTD
14CataractOFFSIDES
15Cerebral atrophyOFFSIDES
16Chemical and Drug Induced Liver Injury12910067
24085192		CTD
17Cholestasis12910067CTD
18ChromaturiaOFFSIDES
19ConfabulationOFFSIDES
20Creatinine renal clearance decreasedOFFSIDES
21Cytolytic hepatitisOFFSIDES
22Device FailureOFFSIDES
23Device ineffectiveOFFSIDES
24Diastolic dysfunctionOFFSIDES
25Drug dose omissionOFFSIDES
26DysgraphiaOFFSIDES
27Dyslipidemias9515185CTD
28EnteritisOFFSIDES
29ErythemaOFFSIDES
30Gastric ulcerOFFSIDES
31Gastrointestinal inflammationOFFSIDES
32GranulocytosisOFFSIDES
33GranulomaOFFSIDES
34Hepatomegaly2390105CTD
35Hypercholesterolemia2045526
2492189		CTD
36Hypertriglyceridemia8593127CTD
37HysterectomyOFFSIDES
38IncoherentOFFSIDES
39Intestinal infarctionOFFSIDES
40Kidney Diseases11096145CTD
41Kidney FailureOFFSIDES
42LipaseOFFSIDES
43Liver neoplasms1370768
8425263
12771043		CTD
44Lung Neoplasms2891433CTD
45Neoplasm Metastasis2891433CTD
46Nephrogenic Fibrosing DermopathyOFFSIDES
47PhlebitisOFFSIDES
48PleurisyOFFSIDES
49Precancerous Conditions1973356CTD
50Pseudomyxoma PeritoneiOFFSIDES
51Respiratory FailureOFFSIDES
52Retroperitoneal fibrosisOFFSIDES
53Rhabdomyolysis8976986CTD
OFFSIDES
54Septic ShockOFFSIDES
55Superinfection lungOFFSIDES
56Transaminases increasedOFFSIDES
57Troponin increasedOFFSIDES
58furuncleOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.